Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA

Research output: Contribution to journalArticle

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that act as master regulators of many cellular processes. The expression of miRNAs is often deregulated in human tumors, causing the alteration of molecular mechanisms relevant for cancer progression. Importantly, miRNAs are detectable in the blood and their quantity fluctuations are the hallmark of pathogenic conditions, including cancer. Several groups reported the identification of circulating cell-free miRNAs (cf-miRNAs) in the human serum and plasma and demonstrated their diagnostic and prognostic utility. Other studies also shown that it may be feasible to apply such cf-miRNA signatures within screening programs in order to improve cancer early detection. Circulating cf-miRNAs therefore appear to be excellent candidates for blood-borne cancer biomarkers.

Original languageEnglish
Pages (from-to)4-6
Number of pages3
JournalEBioMedicine
Volume5
DOIs
Publication statusPublished - Mar 2016

Fingerprint

Tumor Biomarkers
MicroRNAs
Macros
Blood
Small Untranslated RNA
Neoplasms
Social Identification
Early Detection of Cancer
Tumors
Screening
Plasmas
Serum

Keywords

  • Biomarkers, Tumor
  • Early Detection of Cancer
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs
  • Neoplasms
  • Neoplastic Cells, Circulating
  • Prognosis
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review

Cite this

Circulating Cancer Biomarkers : The Macro-revolution of the Micro-RNA. / Montani, Francesca; Bianchi, Fabrizio.

In: EBioMedicine, Vol. 5, 03.2016, p. 4-6.

Research output: Contribution to journalArticle

@article{9dd76af928ac4f81a3b21cc4d869ecfd,
title = "Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA",
abstract = "MicroRNAs (miRNAs) are small non-coding RNAs that act as master regulators of many cellular processes. The expression of miRNAs is often deregulated in human tumors, causing the alteration of molecular mechanisms relevant for cancer progression. Importantly, miRNAs are detectable in the blood and their quantity fluctuations are the hallmark of pathogenic conditions, including cancer. Several groups reported the identification of circulating cell-free miRNAs (cf-miRNAs) in the human serum and plasma and demonstrated their diagnostic and prognostic utility. Other studies also shown that it may be feasible to apply such cf-miRNA signatures within screening programs in order to improve cancer early detection. Circulating cf-miRNAs therefore appear to be excellent candidates for blood-borne cancer biomarkers.",
keywords = "Biomarkers, Tumor, Early Detection of Cancer, Gene Expression Regulation, Neoplastic, Humans, MicroRNAs, Neoplasms, Neoplastic Cells, Circulating, Prognosis, Journal Article, Research Support, Non-U.S. Gov't, Review",
author = "Francesca Montani and Fabrizio Bianchi",
year = "2016",
month = "3",
doi = "10.1016/j.ebiom.2016.02.038",
language = "English",
volume = "5",
pages = "4--6",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Circulating Cancer Biomarkers

T2 - The Macro-revolution of the Micro-RNA

AU - Montani, Francesca

AU - Bianchi, Fabrizio

PY - 2016/3

Y1 - 2016/3

N2 - MicroRNAs (miRNAs) are small non-coding RNAs that act as master regulators of many cellular processes. The expression of miRNAs is often deregulated in human tumors, causing the alteration of molecular mechanisms relevant for cancer progression. Importantly, miRNAs are detectable in the blood and their quantity fluctuations are the hallmark of pathogenic conditions, including cancer. Several groups reported the identification of circulating cell-free miRNAs (cf-miRNAs) in the human serum and plasma and demonstrated their diagnostic and prognostic utility. Other studies also shown that it may be feasible to apply such cf-miRNA signatures within screening programs in order to improve cancer early detection. Circulating cf-miRNAs therefore appear to be excellent candidates for blood-borne cancer biomarkers.

AB - MicroRNAs (miRNAs) are small non-coding RNAs that act as master regulators of many cellular processes. The expression of miRNAs is often deregulated in human tumors, causing the alteration of molecular mechanisms relevant for cancer progression. Importantly, miRNAs are detectable in the blood and their quantity fluctuations are the hallmark of pathogenic conditions, including cancer. Several groups reported the identification of circulating cell-free miRNAs (cf-miRNAs) in the human serum and plasma and demonstrated their diagnostic and prognostic utility. Other studies also shown that it may be feasible to apply such cf-miRNA signatures within screening programs in order to improve cancer early detection. Circulating cf-miRNAs therefore appear to be excellent candidates for blood-borne cancer biomarkers.

KW - Biomarkers, Tumor

KW - Early Detection of Cancer

KW - Gene Expression Regulation, Neoplastic

KW - Humans

KW - MicroRNAs

KW - Neoplasms

KW - Neoplastic Cells, Circulating

KW - Prognosis

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

KW - Review

U2 - 10.1016/j.ebiom.2016.02.038

DO - 10.1016/j.ebiom.2016.02.038

M3 - Article

C2 - 27077096

VL - 5

SP - 4

EP - 6

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

ER -